Quantitative proteomics reveals novel therapeutic and diagnostic markers in hypertension.
BBA Clin
; 2: 79-87, 2014 Dec.
Article
en En
| MEDLINE
| ID: mdl-26672470
Hypertension is a prevalent disorder in the world representing one of the major risk factors for heart attack and stroke. These risks are increased in salt sensitive individuals. Hypertension and salt sensitivity are complex phenotypes whose pathophysiology remains poorly understood and, remarkably, salt sensitivity is still laborious to diagnose. Here we present a urinary proteomic study specifically designed to identify urinary proteins relevant for the pathogenesis of hypertension and salt sensitivity. Despite previous studies that underlined the association of UMOD gene variants with hypertension, this work provides novel evidence showing different uromodulin protein level in the urine of hypertensive patients compared to healthy individuals. Notably, we also show that patients with higher level of uromodulin are homozygous for UMOD risk variant and display a decreased level of salt excretion, highlighting the essential role of UMOD in the regulation of salt reabsorption in hypertension. Additionally, we found that urinary nephrin 1, a marker of glomerular slit diaphragm, may predict a salt sensitive phenotype and positively correlate with increased albuminuria associated with this type of hypertension.
BMI, body mass index; BP, blood pressure; DBP, diastolic BP; GO, Gene Ontology; Glomerular injury; LCMS/MS, liquid chromatography coupled to tandem mass spectrometry; MBP, mean BP.; MQ, MaxQuant; Nephrinuria; Quantitative proteomics; SBP, systolic BP; SR, salt resistant; SS, salt sensitive; Salt homeostasis; Salt sensitive hypertension; Urinary biomarker; Uromodulin
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
BBA Clin
Año:
2014
Tipo del documento:
Article
País de afiliación:
Italia
Pais de publicación:
Países Bajos